The risk of AVM rupture was evaluated within the A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) demo. This research uncovered a lowered risk of stroke and mortality in sufferers managed conservatively vs . patients who underwent interventional therapy.[13]  The ARUBA trial as opposed healthcare management by itself to https://www.sgvascularctr.com/service/vascular-malformations/